Potent PDE4 inhibitor activates AMPK and Sirt1 to induce mitochondrial biogenesis.
AMP-activated protein kinase (AMPK) is an evolutionarily conserved energy sensor. Activation of AMPK leads to a number of metabolic benefits, including improved mitochondrial function in skeletal muscle and lowering of serum glucose levels in type-2 diabetes models. However, direct activation of AMP...
Guardado en:
Autores principales: | Sung-Jun Park, Faiyaz Ahmad, Robert J Bahde, Andrew Philp, Jeonghan Kim, Tianjiao Huang, Myung K Kim, William C Trenkle, Jay H Chung |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/feec3c253475457eb9c0174e3e2d56d8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The protective effect of the PDE-4 inhibitor rolipram on intracerebral haemorrhage is associated with the cAMP/AMPK/SIRT1 pathway
por: Xiao-Liu Dong, et al.
Publicado: (2021) -
Identification of pyrazolopyridazinones as PDEδ inhibitors
por: Björn Papke, et al.
Publicado: (2016) -
Chronic Activation of AMPK Induces Mitochondrial Biogenesis through Differential Phosphorylation and Abundance of Mitochondrial Proteins in <i>Dictyostelium discoideum</i>
por: Malgorzata Heidorn-Czarna, et al.
Publicado: (2021) -
SIRT1 promotes lipid metabolism and mitochondrial biogenesis in adipocytes and coordinates adipogenesis by targeting key enzymatic pathways
por: Yasser Majeed, et al.
Publicado: (2021) -
The hepatic AMPK-TET1-SIRT1 axis regulates glucose homeostasis
por: Chunbo Zhang, et al.
Publicado: (2021)